CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
CytRx reports 2018 executive compensation
By ExecPay News
Published: June 26, 2019
CytRx reported fiscal year 2018 executive compensation information on June 26, 2019.
In 2018, three CytRx executives received on average a compensation package of $605K, a 37% decrease compared to previous year.
Average pay of disclosed executives at CytRx
Steven A. Kriegsman, Chief Executive Officer, received $1M in total, which decreased by 48% compared to 2017. 84% of Kriegsman's compensation, or $850K, was in salary. Kriegsman also received $150K in bonus and $14K in other compensation.
John Y. Caloz, Chief Financial Officer, received a compensation package of $500K, which decreased by 13% compared to previous year. 80% of the compensation package, or $400K, was in salary.
Felix Kratz, Vice President – Drug Development, earned $302K in 2018, a 9% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on June 26, 2019.